Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Personalized treatment plans are important for people with alopecia areata.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Lupus can cause hair loss and nail changes, with treatments available for both.

Hydroxychloroquine may help treat alopecia areata in children.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Adalimumab helped control a child's severe eye disease when other treatments failed.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Niosomes are a promising and effective way to deliver drugs through the skin.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Some cancer treatments can cause permanent hair loss.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

COVID-19 doesn't make alopecia areata worse.